Dose Monitoring of Lamotriginxe Monotherapy in Pregnancy: Are Pregnant Women with Epilepsy Currently Optimally Managed? A Systematic Review.
Yeonkyung GooAnne Marijn der NederlandenAndrew BleaselJan-Willem AlffenaarHannah Yejin KimPublished in: Therapeutic drug monitoring (2024)
Further studies are required to establish evidence-based standardized protocols encompassing all aspects of TDM. Early interventions, such as empirical dose increases during pregnancy and postpartum tapering, and routine monitoring from preconception to the postpartum period may enhance seizure control, reducing the risk of breakthrough seizures for the mother and unborn child.